Bull
$4.85
Scenario price
$15.420
+0.327 (+2.12%)At close
FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand. It designs and sells scrub wear and non-scrub wear, such as outerwear, under scrubs, footwear, compression socks, lab coats, lounge wear and other apparel. It markets and sells its products primarily in the United States. It designs all its products in-house, leverages third-party suppliers and manufacturers to produce its product components and finished products, and generally uses shallow initial buys and data-driven repurchasing decisions to test new products. It directly and actively coordinates with its suppliers at every step of its product development and production process to ensure that its quality standards are met. Its under scrubs include performance tops, and super-soft Pima cotton tops. Its outer layer products include footwear, lab coats and a variety of vests, jackets and fleeces. Its non-scrub wear product offerings include its lounge wear, which is its collection designed for off-shift moments.
Figs Inc is a good buy right now due to its recent strong performance, including a 29% year-over-year sales increase to $196.6 million in Q2 2026, and a significant rise in net income to $28.4 million in the same quarter. The stock's current price of $15.42 is well below the average analyst price target of $20, suggesting a potential upside of 29%. However, the main risk is the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Abercrombie & Fitch and Others Surge in August Stock Performance

Consumer Stocks Surge in August Defying Economic Gloom

FIGS (FIGS) Q2 2026 Earnings Call Transcript

Figs Stock Continues to Rise, Analysts Optimistic About Future

Figs Surpasses Earnings Expectations, Stock Continues to Rise
FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand. It designs and sells scrub wear and non-scrub wear, such as outerwear, under scrubs, footwear, compression socks, lab coats, lounge wear and other apparel. It markets and sells its products primarily in the United States. It designs all its products in-house, leverages third-party suppliers and manufacturers to produce its product components and finished products, and generally uses shallow initial buys and data-driven repurchasing decisions to test new products. It directly and actively coordinates with its suppliers at every step of its product development and production process to ensure that its quality standards are met. Its under scrubs include performance tops, and super-soft Pima cotton tops. Its outer layer products include footwear, lab coats and a variety of vests, jackets and fleeces. Its non-scrub wear product offerings include its lounge wear, which is its collection designed for off-shift moments. It operates in the Consumer Cyclicals sector (APPAREL & OTHER FINISHD PRODS OF FABRICS & SIMILAR industry).
Figs Inc is a good buy right now due to its recent strong performance, including a 29% year-over-year sales increase to $196.6 million in Q2 2026, and a significant rise in net income to $28.4 million in the same quarter. The stock's current price of $15.42 is well below the average analyst price target of $20, suggesting a potential upside of 29%. However, the main risk is the forward P/E ratio of 49.02, which indicates that the stock may be overvalued if growth does not meet expectations.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.